$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
Bank of America Corp DE Has $1.30 Million Stock Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
08:55am, Thursday, 23'rd Apr 2020
Bank of America Corp DE increased its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) by 273.7% during the 4th quarter, according to its most recent filing with the Securities and E
Gilead, markets fall after report of disappointing COVID-19 trial GILD;SPY;SPX;BCRX
06:01am, Thursday, 23'rd Apr 2020
Gilead, markets fall after report of disappointing COVID-19 trial GILD SPY SPX BCRX
Fred Cohen Investor Profile: Portfolio & Exits | PitchBook
06:05pm, Wednesday, 22'nd Apr 2020
Information on investments, active portfolio, exits, fund performance, dry powder, team and co-investors for Fred Cohen. Use the PitchBook Platform to explore the full profile.
Clearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors
11:05am, Wednesday, 22'nd Apr 2020
Clearside Biomedical, Inc. (CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, ann
BioCryst to Report First Quarter 2020 Financial Results on May 6
11:00am, Wednesday, 22'nd Apr 2020
RESEARCH TRIANGLE PARK, N.C., April 22, 2020 -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2020 financial.
BioCryst to Report First Quarter 2020 Financial Results on May 6
11:00am, Wednesday, 22'nd Apr 2020
RESEARCH TRIANGLE PARK, N.C., April 22, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will...
How Does BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Affect Your Portfolio Volatility?
10:16am, Wednesday, 22'nd Apr 2020
If you're interested in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), then you might want to consider its beta (a...
Bank of New York Mellon Corp Increases Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
09:50am, Wednesday, 22'nd Apr 2020
Bank of New York Mellon Corp lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) by 25.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm own
RedHill's Oncology Candidate to be Tested for Coronavirus
04:19pm, Tuesday, 21'st Apr 2020
RedHill (RDHL) inks a deal with NIAID for non-clinical testing of its investigational candidate RHB-107 to evaluate its activity against COVID-19. Stock up.
RedHill's Oncology Candidate to be Tested for Coronavirus
04:19pm, Tuesday, 21'st Apr 2020
RedHill (RDHL) inks a deal with NIAID for non-clinical testing of its investigational candidate RHB-107 to evaluate its activity against COVID-19. Stock up.
The legacy of Kleiner Perkins' 2006 pandemic fund
02:15pm, Tuesday, 21'st Apr 2020
14 years ago, Kleiner Perkins raised $200 million VC fund focused on pandemic preparedness. Now it's paying off.
Top Ranked Momentum Stocks to Buy for April 20th
01:06pm, Monday, 20'th Apr 2020
Top Ranked Momentum Stocks to Buy for April 20th
Top Ranked Momentum Stocks to Buy for April 20th
01:06pm, Monday, 20'th Apr 2020
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 20th
BioCryst call buyer realizes 101% same-day gains BCRX
12:39pm, Monday, 20'th Apr 2020
BioCryst call buyer realizes 101% same-day gains BCRX
Does BioCryst Pharmaceuticals (NASDAQ:BCRX) Have A Healthy Balance Sheet?
12:56pm, Saturday, 18'th Apr 2020
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Sign In
Buy BCRX